Biomarin Pharmaceutical Inc (BMRN)
$66.43 $0.14 (0.22%) 4:37 PM 12/10/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$12.72B -
Day's Range
$66.29 - $67.06 -
Volume
1,585,987 -
52 Week Low / High
$61.15 - $99.56 -
PE Ratio
40.20x -
PEG Ratio
0.42 -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 14
- Strong Buy
- 8
- Buy
- 5
- Hold
- 0
- Sell
- 0
- Strong Sell
- $116.95
- Target Price
Company News
-
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock — Oct 17th, 2024
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to us...
-
BMRN or MYGN: Which Is the Better Value Stock Right Now? — Oct 1st, 2024
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with BioMarin Pharmaceutical (BMRN) and Myriad Genetics (MYGN). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. There are plenty of ...
-
BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET — Oct 16th, 2024
SAN RAFAEL, Calif., Oct. 16, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Tuesday, October 29, 2024, at 4:30 p.m. ET to discuss third quar...
-
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock — Oct 17th, 2024
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to us...
-
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock — Oct 17th, 2024
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to us...
-
Do Options Traders Know Something About BioMarin (BMRN) Stock We Don't? — Oct 4th, 2024
Investors in BioMarin Pharmaceutical Inc. BMRN need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 18, 2024 $55.00 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...
-
BMRN or MYGN: Which Is the Better Value Stock Right Now? — Oct 1st, 2024
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with BioMarin Pharmaceutical (BMRN) and Myriad Genetics (MYGN). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. There are plenty of ...
-
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick — Oct 1st, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your pr...
-
BMRN or MYGN: Which Is the Better Value Stock Right Now? — Oct 1st, 2024
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with BioMarin Pharmaceutical (BMRN) and Myriad Genetics (MYGN). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. There are plenty of ...
-
BMRN or MYGN: Which Is the Better Value Stock Right Now? — Oct 1st, 2024
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with BioMarin Pharmaceutical (BMRN) and Myriad Genetics (MYGN). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. There are plenty of ...
-
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick — Oct 1st, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your pr...
-
Do Options Traders Know Something About BioMarin (BMRN) Stock We Don't? — Oct 4th, 2024
Investors in BioMarin Pharmaceutical Inc. BMRN need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 18, 2024 $55.00 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...
-
BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET — Oct 16th, 2024
SAN RAFAEL, Calif., Oct. 16, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Tuesday, October 29, 2024, at 4:30 p.m. ET to discuss third quar...
-
Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN) — Oct 1st, 2024
BioMarin Pharmaceutical (BMRN) has been beaten down lately with too much selling pressure. While the stock has lost 22.9% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnin...
-
Do Options Traders Know Something About BioMarin (BMRN) Stock We Don't? — Oct 4th, 2024
Investors in BioMarin Pharmaceutical Inc. BMRN need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 18, 2024 $55.00 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...
-
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock — Oct 17th, 2024
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to us...
-
Do Options Traders Know Something About BioMarin (BMRN) Stock We Don't? — Oct 4th, 2024
Investors in BioMarin Pharmaceutical Inc. BMRN need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 18, 2024 $55.00 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...
-
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick — Oct 1st, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your pr...
-
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock — Oct 17th, 2024
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to us...
-
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock — Oct 17th, 2024
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to us...
-
BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET — Oct 16th, 2024
SAN RAFAEL, Calif., Oct. 16, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Tuesday, October 29, 2024, at 4:30 p.m. ET to discuss third quar...
-
3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN) — Oct 1st, 2024
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task. In addition to volatility, these ...
-
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock — Oct 17th, 2024
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to us...
-
BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET — Oct 16th, 2024
SAN RAFAEL, Calif., Oct. 16, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Tuesday, October 29, 2024, at 4:30 p.m. ET to discuss third quar...
-
BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET — Oct 16th, 2024
SAN RAFAEL, Calif., Oct. 16, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Tuesday, October 29, 2024, at 4:30 p.m. ET to discuss third quar...
-
Do Options Traders Know Something About BioMarin (BMRN) Stock We Don't? — Oct 4th, 2024
Investors in BioMarin Pharmaceutical Inc. BMRN need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 18, 2024 $55.00 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...
-
BMRN or MYGN: Which Is the Better Value Stock Right Now? — Oct 1st, 2024
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with BioMarin Pharmaceutical (BMRN) and Myriad Genetics (MYGN). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. There are plenty of ...
-
Do Options Traders Know Something About BioMarin (BMRN) Stock We Don't? — Oct 4th, 2024
Investors in BioMarin Pharmaceutical Inc. BMRN need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 18, 2024 $55.00 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...
-
3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN) — Oct 1st, 2024
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task. In addition to volatility, these ...
-
BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET — Oct 16th, 2024
SAN RAFAEL, Calif., Oct. 16, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Tuesday, October 29, 2024, at 4:30 p.m. ET to discuss third quar...
-
3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN) — Oct 1st, 2024
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task. In addition to volatility, these ...
-
BMRN or MYGN: Which Is the Better Value Stock Right Now? — Oct 1st, 2024
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with BioMarin Pharmaceutical (BMRN) and Myriad Genetics (MYGN). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. There are plenty of ...
-
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick — Oct 1st, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your pr...
-
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock — Oct 17th, 2024
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to us...
-
Do Options Traders Know Something About BioMarin (BMRN) Stock We Don't? — Oct 4th, 2024
Investors in BioMarin Pharmaceutical Inc. BMRN need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 18, 2024 $55.00 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...
-
BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET — Oct 16th, 2024
SAN RAFAEL, Calif., Oct. 16, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Tuesday, October 29, 2024, at 4:30 p.m. ET to discuss third quar...
-
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick — Oct 1st, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your pr...
-
3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN) — Oct 1st, 2024
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task. In addition to volatility, these ...
-
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock — Oct 17th, 2024
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to us...
-
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick — Oct 1st, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your pr...
-
3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN) — Oct 1st, 2024
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task. In addition to volatility, these ...
-
3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN) — Oct 1st, 2024
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task. In addition to volatility, these ...
-
Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN) — Oct 1st, 2024
BioMarin Pharmaceutical (BMRN) has been beaten down lately with too much selling pressure. While the stock has lost 22.9% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnin...
-
Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN) — Oct 1st, 2024
BioMarin Pharmaceutical (BMRN) has been beaten down lately with too much selling pressure. While the stock has lost 22.9% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnin...
-
Do Options Traders Know Something About BioMarin (BMRN) Stock We Don't? — Oct 4th, 2024
Investors in BioMarin Pharmaceutical Inc. BMRN need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 18, 2024 $55.00 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...
-
Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN) — Oct 1st, 2024
BioMarin Pharmaceutical (BMRN) has been beaten down lately with too much selling pressure. While the stock has lost 22.9% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnin...
-
Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN) — Oct 1st, 2024
BioMarin Pharmaceutical (BMRN) has been beaten down lately with too much selling pressure. While the stock has lost 22.9% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnin...
-
BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET — Oct 16th, 2024
SAN RAFAEL, Calif., Oct. 16, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Tuesday, October 29, 2024, at 4:30 p.m. ET to discuss third quar...
-
Do Options Traders Know Something About BioMarin (BMRN) Stock We Don't? — Oct 4th, 2024
Investors in BioMarin Pharmaceutical Inc. BMRN need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 18, 2024 $55.00 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied v...
-
Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN) — Oct 1st, 2024
BioMarin Pharmaceutical (BMRN) has been beaten down lately with too much selling pressure. While the stock has lost 22.9% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnin...
Portfolio
Comprised of 1 portfolios